U.S. Craniomaxillofacial (CMF) Devices/System Market Analysis Report By Material (Bioabsorbable, Metal), By Application, By Product (MF Plate, Temporomandibular Joint Replacement), And Segment Forecasts, 2018 - 2025

Published: Dec, 2018 | Pages: 71 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)

The U.S. craniomaxillofacial (CMF) devices/systems market size is poised to reach USD 1.62 billion by 2025, according to a new report by Grand View Research, Inc., rising at a CAGR of 6.9% during the forecast period. Increasing demand for cranial and facial surgeries is poised to drive the market over the forecast period.

Increasing incidence of sports injuries and road accidents due to industrialization and urbanization has also been providing an upthrust to the U.S. craniomaxillofacial devices market. According to the Wimbledon Clinics Report in 2015, kickboxing caused 2.5 facial injuries per hour and the rate was higher than other combat sports.

Further key findings from the report suggest:

• Surging demand for minimally invasive surgeries is projected to boost the demand for craniomaxillofacial devices in the U.S. during the forecast period

• Temporomandibular joint replacement is anticipated to post the highest CAGR over the forecast period, owing to increasing incidence of trauma related to sports injuries and cranial fractures

• Metallic CMF implants accounted for the largest revenue share in 2017, owing to increasing use of metal 3D implants manufacturing

• Bioabsorbable material is estimated to register a lucrative CAGR of 7.3% during the same period due to ease with which they assimilate in human body. The other advantages include ability to transfer gradual load to healing tissues and radiolucency

• Plastic surgeries are expected to show steady growth during the same period, due to burgeoning popularity of the facial augmentation procedure and growing awareness regarding use of CMF devices. According to the American Society of Plastic Surgeons (ASPS), USD 16.0 billion were spent on cosmetic surgeries in 2016

• Favorable government policies supporting orthognathic surgeries are also likely to stoke the growth of the market

• Key companies operating in the U.S. craniomaxillofacial devices market are Stryker Corporation; Medtronic Plc; Zimmer-Biomet Inc.; and Medartis AG.

 Table of Contents

Chapter 1 Research Methodology & Scope
                   1.1 Region Wise Market Calculation
                       1.1.1 Region wise market: Base estimates
                       1.1.2 U.S. market: CAGR calculation
                   1.2 Region based segment share calculation
                       1.2.1 Factors used in segment share estimation
                   1.3 Primary Sources
                   1.4 List of Secondary Sources

Chapter 2 Executive Summary
                   2.1 Market Snapshot

Chapter 3 Market Variables, Trends& Scope
                   3.1 Market Segmentation & Scope
                   3.2 Market Driver Analysis
                       3.2.1 Increasing incidence of sports and facial fractures
                       3.2.2 Rising demand for minimally invasive surgeries
                       3.2.3 Technological advancements in management of craniomaxillofacial injuries
                   3.3 Market Restraint Analysis
                       3.3.1 Lack of reimbursement policies for patient specific devices
                   3.4 Penetration & Growth Prospect Mapping
                   3.5 U.S. Craniomaxillofacial Devices - SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
                   3.6 U.S. Craniomaxillofacial Devices: Competitive Landscape, 2017
                       3.6.1 U.S. Company market share analysis, 2017
                   3.7 Industry Analysis - Porter's 
                   3.8 Regulatory Scenario
                   3.9 Reimbursement Structure 

Chapter 4 U.S. CMF Devices Market : Product Estimates & Trend Analysis
                   4.1 U.S. Craniomaxillofacial Devices Market: Product Movement Analysis
                   4.2 Cranial Flap Fixation Market
                       4.2.1 Cranial flap fixation market, 2014 - 2025 (USD Million)
                   4.3 CMF Distraction
                       4.3.1 CMF distraction market, 2014 - 2025 (USD Million)
                   4.4 Temporomandibular Joint
                       4.4.1 Temporomandibular joint market, 2014 - 2025 (USD Million)
                   4.5 Thoracic Fixation
                       4.5.1 Thoracic fixation market, 2014 - 2025 (USD Million)
                   4.6 Bone Graft Substitutes (BGS)
                       4.6.1 Bone graft substitutes market, 2014 - 2025 (USD Million)
                   4.7 Metal Facial (MF) Plate And Screw Fixation
                       4.7.1 MF plate and screw fixation market, 2014 - 2025 (USD Million)

Chapter 5 U.S. CMF Devices Market: Material Estimates & Trend Analysis
                   5.1 U.S. Craniomaxillofacial Devices Market: Material Movement Analysis
                   5.2 Metals
                       5.2.1 Metals market, 2014 - 2025 (USD Million)
                   5.3 Bioabsorbable
                       5.3.1 Bioabsorbable market, 2014 - 2025 (USD Million)
                   5.4 Ceramic
                       5.4.1 Ceramic market, 2014 - 2025 (USD Million)

Chapter 6 U.S. CMF Devices Market: Application Estimates & Trend Analysis
                   6.1 U.S. Craniomaxillofacial Devices Market: Application Movement Analysis
                   6.2 Neurosurgery and ENT Surgery
                       6.2.1 Neurosurgery and ENT market, 2014 - 2025 (USD Million)
                   6.3 Orthognathic and Dental Surgery
                       6.3.1 Orthognathic and dental surgery market, 2014 - 2025 (USD Million)
                   6.4 Plastic surgery
                       6.4.1 Plastic surgery market, 2014 - 2025 (USD Million)

Chapter 7 Competitive Landscape
                   7.1 Strategy Framework
                   7.2 Company Profiles
                       7.2.1 Stryker
                           7.2.1.1 Company overview
                           7.2.1.2 Financial performance
                           7.2.1.3 Product benchmarking
                           7.2.1.4 Strategic initiatives
                       7.2.2 Medtronic
                           7.2.2.1 Company overview
                           7.2.2.2 Financial performance
                           7.2.2.3 Product benchmarking
                           7.2.2.4 Strategic initiatives
                       7.2.3 KLS Martin Group
                           7.2.3.1 Company overview
                           7.2.3.2 Product benchmarking
                           7.2.3.3 Strategic initiatives
                       7.2.4 Medartis AG
                           7.2.4.1 Company overview
                           7.2.4.2 Product benchmarking
                           7.2.4.3 Strategic initiatives
                       7.2.5 Johnson & Johnson
                           7.2.5.1 Company overview
                           7.2.5.2 Financial performance
                           7.2.5.3 Product benchmarking
                           7.2.5.4 Strategic initiatives
                       7.2.6 W. L. Gore & Associates, Inc.
                           7.2.6.1 Company overview
                           7.2.6.2 Product benchmarking
                           7.2.6.3 Strategic initiatives
                       7.2.7 TMJ Concepts
                           7.2.7.1 Company overview
                           7.2.7.2 Product benchmarking
                       7.2.8 Integra LifeSciences
                           7.2.8.1 Company overview
                           7.2.8.2 Financial performance
                           7.2.8.3 Product benchmarking
                           7.2.8.4 Strategic initiatives
                       7.2.9 OsteoMed
                           7.2.9.1 Company overview
                           7.2.9.2 Product benchmarking
                           7.2.9.3 Strategic initiatives
                       7.2.10 Aesculap Implant Systems, LLC
                           7.2.10.1 Company overview
                           7.2.10.2 Product benchmarking
                           7.2.10.3 Strategic initiatives
                       7.2.11 Zimmer Biomet
                           7.2.11.1 Company overview
                           7.2.11.2 Financial performance
                           7.2.11.3 Product benchmarking
                           7.2.11.4 Strategic initiatives